Evidence map›Paper›PMID 35888175›Full record

ReviewLife (Basel, Switzerland)2022

How an Outbreak of COVID-19 Circulated Widely in Nepal: A Chronological Analysis of the National Response to an Unprecedented Pandemic.

Basu Dev Pandey, Mya Myat Ngwe Tun, Kishor Pandey, Shyam Prakash Dumre, Khin Mya Nwe, Yogendra Shah, Richard Culleton, Yuki Takamatsu, Anthony Costello, Kouichi Morita

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Impact of COVID-19 among women seeking abortion services in Nepal: results from a longitudinal study.Archives of public health = Archives belges de sante publique · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. COVID-19 Prevention and Treatment.Life (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Basu Dev PandeyDepartment of Molecular Epidemiology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Mya Myat Ngwe TunDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Kishor PandeyCentral Department of Zoology, Tribhuvan University, Kathmandu 44618, Nepal.
Shyam Prakash DumreCentral Department of Microbiology, Tribhuvan University, Kathmandu 44618, Nepal.
Khin Mya NweDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Yogendra ShahSeti Provincial Hospital, Kailali 10900, Nepal.ORCID 0000-0002-0820-4556
Richard CulletonDivision of Molecular Parasitology, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.ORCID 0000-0001-8808-5771
Yuki TakamatsuDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Anthony CostelloInstitute for Global Health, University College London, London WC1N 1EH, UK.
Kouichi MoritaDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Funding

Japan Agency for Medical Research and Development JP21wm0125006
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first COVID-19 case was reported in Wuhan, China, in December 2019. In March 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. The first COVID-19 case in Nepal was reported in January 2020 in a Nepalese man who had returned from Wuhan to Nepal. This study aims to evaluate the government of Nepal's (GoN) response to the COVID-19 pandemic and explore ways to prevent COVID-19 and other pandemic diseases in the future. As of May 2022, a total of 979,140 cases and 11,951 deaths associated with COVID-19 have been reported in Nepal. To prevent the spread of the virus, the GoN initiated various preventive and control measures, including lockdown strategies. The effects of COVID-19 are expected to persist for many years; the best strategies a resource-limited country such as Nepal can implement to control pandemic diseases such as COVID-19 in the pre-vaccine stage are to increase testing, tracing, and isolation capacity.

Indexed as

COVID-19Nepalpandemicvaccine

Identifiers

PMID35888175
PMCPMC9321054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.